Verona Pharma

About:

Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases.

Website: http://www.veronapharma.com

Twitter/X: VeronaPharma

Top Investors: Andera Partners, Hercules Capital, OrbiMed, RA Capital Management, Perceptive Advisors

Description:

Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases, such as asthma, allergic rhinitis (hay fever), chronic obstructive pulmonary disease (COPD) and cough. The company creates therapies to address unmet medical requirements in the treatment of respiratory disorders. Verona Pharma was established in 2005 by Clive Page in London, England.

Total Funding Amount:

$1.51B

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

London, England, United Kingdom

Founded Date:

2005-01-01

Contact Email:

info(AT)veronapharma.com

Founders:

Number of Employees:

51-100

Last Funding Date:

2024-05-09

IPO Status:

Public

© 2025 bioDAO.ai